Frequency of CD45RO+ subset in CD4+CD25high regulatory T cells associated with progression of hepatocellular carcinoma

Cancer Letters

Volumn 307, Issue 2, 2011, Pages 165-173

  Takata, Yoshiko ^a   Nakamoto, Yasunari ^a   Nakada, Akiko ^b   Terashima, Takeshi ^a   Arihara, Fumitaka ^a   Kitahara, Masaaki ^a   Kakinoki, Kaheita ^a   Arai, Kuniaki ^a   Yamashita, Taro ^a   Sakai, Yoshio ^a   Yamashita, Tatsuya ^a   Mizukoshi, Eishiro ^a   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

CD45RO; Dendritic cell; Hepatocellular carcinoma; Intracellular cytokine; Regulatory T cell

Indexed keywords

CD45RO ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

AGED; ANTIGENS, CD45; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 79957660239     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.03.029     Document Type: Article

References (38)

1. Zhou J., Ding T., Pan W., Zhu L.Y., Li L., Zheng L. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Int. J. Cancer 2009, 125:1640-1648.
2. Nakamoto Y., Mizukoshi E., Tsuji H., Sakai Y., Kitahara M., Arai K., Yamashita T., Yokoyama K., Mukaida N., Matsushima K., Matsui O., Kaneko S. Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety. Clin. Exp. Immunol. 2007, 147:296-305.
3. Ormandy L.A., Hillemann T., Wedemeyer H., Manns M.P., Greten T.F., Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 2005, 65:2457-2464.
4. Griffiths R.W., Elkord E., Gilham D.E., Ramani V., Clarke N., Stern P.L., Hawkins R.E. Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival. Cancer Immunol. Immunother. 2007, 56:1743-1753.
5. Visser J., Nijman H.W., Hoogenboom B.N., Jager P., van Baarle D., Schuuring E., Abdulahad W., Miedema F., van der Zee A.G., Daemen T. Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia. Clin. Exp. Immunol. 2007, 150:199-209.
6. Schaefer C., Kim G.G., Albers A., Hoermann K., Myers E.N., Whiteside T.L. Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br. J. Cancer 2005, 92:913-920.
7. Kono K., Kawaida H., Takahashi A., Sugai H., Mimura K., Miyagawa N., Omata H., Fujii H. CD4(+)CD25 high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol. Immunother. 2006, 55:1064-1071.
8. Strauss L., Bergmann C., Gooding W., Johnson J.T., Whiteside T.L. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2007, 13:6301-6311.
9. Wolf A.M., Wolf D., Steurer M., Gastl G., Gunsilius E., Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. 2003, 9:606-612.
10. Ichihara F., Kono K., Takahashi A., Kawaida H., Sugai H., Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin. Cancer Res. 2003, 9:4404-4408.
11. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., Zhang Z., Yang H., Zhang H., Zhou C., Yao J., Jin L., Wang H., Yang Y., Fu Y.X., Wang F.S. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132:2328-2339.
12. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M.L., Knutson K.L., Chen L., Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004, 10:942-949.
13. Unitt E., Rushbrook S.M., Marshall A., Davies S., Gibbs P., Morris L.S., Coleman N., Alexander G.J. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005, 41:722-730.
14. Biagi E., Di Biaso I., Leoni V., Gaipa G., Rossi V., Bugarin C., Renoldi G., Parma M., Balduzzi A., Perseghin P., Biondi A. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007, 84:31-39.
15. Stoop J.N., van der Molen R.G., Baan C.C., van der Laan L.J., Kuipers E.J., Kusters J.G., Janssen H.L. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005, 41:771-778.
16. van Olffen R.W., Koning N., van Gisbergen K.P., Wensveen F.M., Hoek R.M., Boon L., Hamann J., van Lier R.A., Nolte M.A. GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J. Immunol. 2009, 182:7490-7500.
17. Wilde B., Dolff S., Cai X., Specker C., Becker J., Totsch M., Costabel U., Durig J., Kribben A., Tervaert J.W., Schmid K.W., Witzke O. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. Nephrol. Dial. Transplant 2009, 24:161-171.
18. Ahn J.S., Krishnadas D.K., Agrawal B. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Int. Immunol. 2007, 19:227-237.
19. Tang Q., Bluestone J.A. Plasmacytoid DCs and T(reg) cells: casual acquaintance or monogamous relationship?. Nat. Immunol. 2006, 7:551-553.
20. Dumitriu I.E., Dunbar D.R., Howie S.E., Sethi T., Gregory C.D. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 2009, 182:2795-2807.
21. Bayry J., Triebel F., Kaveri S.V., Tough D.F. Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells. J. Immunol. 2007, 178:4184-4193.
22. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
23. Yagi H., Nomura T., Nakamura K., Yamazaki S., Kitawaki T., Hori S., Maeda M., Onodera M., Uchiyama T., Fujii S., Sakaguchi S. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 2004, 16:1643-1656.
24. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
25. Maynard C.L., Harrington L.E., Janowski K.M., Oliver J.R., Zindl C.L., Rudensky A.Y., Weaver C.T. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat. Immunol. 2007, 8:931-941.
26. Freeman C.M., Chiu B.C., Stolberg V.R., Hu J., Zeibecoglou K., Lukacs N.W., Lira S.A., Kunkel S.L., Chensue S.W. CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice. J. Immunol. 2005, 174:1962-1970.
27. Uhlig H.H., Coombes J., Mottet C., Izcue A., Thompson C., Fanger A., Tannapfel A., Fontenot J.D., Ramsdell F., Powrie F. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 2006, 177:5852-5860.
28. Wakkach A., Augier S., Breittmayer J.P., Blin-Wakkach C., Carle G.F. Characterization of IL-10-secreting T cells derived from regulatory CD4+CD25+ cells by the TIRC7 surface marker. J. Immunol. 2008, 180:6054-6063.
29. Torisu M., Murakami H., Akbar F., Matsui H., Hiasa Y., Matsuura B., Onji M. Protective role of interleukin-10-producing regulatory dendritic cells against murine autoimmune gastritis. J. Gastroenterol. 2008, 43:100-107.
30. Bettini M., Vignali D.A. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr. Opin. Immunol. 2009, 21:612-618.
31. Voo K.S., Wang Y.H., Santori F.R., Boggiano C., Arima K., Bover L., Hanabuchi S., Khalili J., Marinova E., Zheng B., Littman D.R., Liu Y.J. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. USA 2009, 106:4793-4798.
32. Schmitz-Winnenthal H., Pietsch D.H., Schimmack S., Bonertz A., Udonta F., Ge Y., Galindo L., Specht S., Volk C., Zgraggen K., Koch M., Buchler M.W., Weitz J., Beckhove P. Chronic pancreatitis is associated with disease-specific regulatory T-cell responses. Gastroenterology 2010, 138:1178-1188.
33. Eksteen B., Neuberger J.M. Mechanisms of disease: the evolving understanding of liver allograft rejection. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008, 5:209-219.
34. Shiina, Kobayashi K., Kobayashi T., Kondo Y., Ueno Y., Shimosegawa T. Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients. J. Gastroenterol. 2006, 41:758-764.
35. Charles J., Di Domizio J., Salameire D., Bendriss-Vermare N., Aspord C., Muhammad R., Lefebvre C., Plumas J., Leccia M.T., Chaperot L. Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor. J. Invest. Dermatol. 2010, 130:646-656.
36. Wei S., Kryczek I., Zou L., Daniel B., Cheng P., Mottram P., Curiel T., Lang A., Zou W. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res. 2005, 65:5020-5026.
37. Kordasti S.Y., Ingram W., Hayden J., Darling D., Barber L., Afzali B., Lombardi G., Wlodarski M.W., Maciejewski J.P., Farzaneh F., Mufti G.J. CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood 2007, 110:847-850.
38. Hoffmann P., Eder R., Boeld T.J., Doser K., Piseshka B., Andreesen R., Edinger M. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006, 108:4260-4267.